RT @NatRevImmunol: Comment article from Xuetao Cao on #COVID19 immunopathology: https://t.co/ZEpuLNVxSY
RT @NatRevImmunol: Comment article from Xuetao Cao on #COVID19 immunopathology: https://t.co/ZEpuLNVxSY
RT @NatRevImmunol: Comment article from Xuetao Cao on #COVID19 immunopathology: https://t.co/ZEpuLNVxSY
RT @NatRevImmunol: Comment article from Xuetao Cao on #COVID19 immunopathology: https://t.co/ZEpuLNVxSY
@tylerwhulett @BernardAFox the Nature article in question (not paper), that you might have read https://t.co/y6gDGZnXbl
RT @NatRevImmunol: Comment article from Xuetao Cao on #COVID19 immunopathology: https://t.co/ZEpuLNVxSY
Great summary of #COVID2019 immunopathology! @humanimmunenews @CdnImmunol @ImmunologyAAI @ImmunologyWars @ImmunoFever @VirusesImmunity @Inmunologia_UMU @SEinmunologia
RT @NatRevImmunol: Comment article from Xuetao Cao on #COVID19 immunopathology: https://t.co/ZEpuLNVxSY
RT @NatRevImmunol: Comment article from Xuetao Cao on #COVID19 immunopathology: https://t.co/ZEpuLNVxSY
Comment article from Xuetao Cao on #COVID19 immunopathology: https://t.co/ZEpuLNVxSY
@PndmcSrvvrsUSA @mlipsitch @StephenKissler @ctedijanto @yhgrad There's a good paper describing 'Immune dysregulation' but our sense is because OC43 and HKU1 are endemic and one would expect previous exposure to be high, wouldn't any ADE effect be more pron
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
SARS-CoV-2感染におけるantibody-dependent enhancement (ADE) を示唆する結果が出てるのか…ワクチン開発が秋の次の流行期に間に合わせるなんて威勢のいい話が出てるけど、そうすんなり行くかどうか…
@pauliepg11111 https://t.co/7rwRNv9YnW Nature confirms evidence for ADE in covid Covid is able to trick the body into an immune response that produces antibodies which instead of neutralizing the virus, actually help the virus infect even more cells. This
Fresh review! Cao, X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol (2020). https://t.co/FTNwI2gmPi
Fresh review: https://t.co/70OtJxhbmH
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
COVID-19 :Inmunopatología y sus implicaciones para la terapia #nature #COVID19 https://t.co/KRmu61m8C6
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
The plot thickens...
Definitivamente habrá que pendar encontrar algún farmaco contra forma severa CoV-2, antes vacuna.
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
RT @ASOCHIN_Oficial: Review "COVID-19: immunopathology and its implications for therapy" https://t.co/smmAbeSETm
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
RT @ASOCHIN_Oficial: Review "COVID-19: immunopathology and its implications for therapy" https://t.co/smmAbeSETm
RT @burgospa: 👇🏻 autoridades, las dudas respecto a las medidas recién anunciadas son válidas, detectar anticuerpos en sangre NO indica nece…
RT @Fbosorioo: Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciacion…
RT @ASOCHIN_Oficial: Review "COVID-19: immunopathology and its implications for therapy" https://t.co/smmAbeSETm
👇🏻 autoridades, las dudas respecto a las medidas recién anunciadas son válidas, detectar anticuerpos en sangre NO indica necesariamente protección, a veces todo lo contrario “anticuerpos patogénicos”. Faltan aún estudios, no seamos tan acelerados en comuni
RT @ASOCHIN_Oficial: Review "COVID-19: immunopathology and its implications for therapy" https://t.co/smmAbeSETm
Review "COVID-19: immunopathology and its implications for therapy" https://t.co/smmAbeSETm
Update de lo que sabemos acerca de la respuesta inmune protectora versus la inmunopatologia de COVID-19, también apreciaciones muy importantes a considerar en el diseño de terapias https://t.co/L0Wt7kKAzU https://t.co/t4UWcSYs5X
More evidence for and against the dreaded ADE #coronavirus #Covid_19 #COVID19de https://t.co/626x0eZKDC
@theRealKiyosaki Nature confirms evidence for ADE in covid https://t.co/7rwRNv9YnW The virus is able to trick the body into an immune response that produces antibodies which instead of neutralizing the virus, actually help the virus infect even more cell
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
COVID-19: immunopathology and its implications for therapy | Nature Reviews Immunology https://t.co/g684qC7Erh
COVID-19: immunopathology and its implications for therapy https://t.co/xGCC4ckuve
@niro60487270 no. HCQ doesnt interact with the virus so that irrelevant. Its used in lupus/RA patients as immunodulatory and if it demonstrated any benefit in influenza pneumonia it would translate https://t.co/1QY6w34mXk
Immunopathological features of Severe disease- pneumonia, lymphopenia, exhausted lymphocytes and a cytokine storm! https://t.co/IIaz1TGGpr
COVID-19: immunopathology and its implications for therapy | Nature Reviews Immunology https://t.co/bgEe3RSQ8N
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
The possible ADE worries me... https://t.co/tWmqgPHFVj
« In addition, exhaustion markers, such as NKG2A, on cytotoxic lymphocytes, including NK cells and CD8+ T cells, are upregulated in patients with COVID-19 » Monalizumab, anti-NKg2a, innate pharma
Update on COVID-19: maybe we will need less antibodies ... https://t.co/UOakrwF8vC
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
$CHFS #CytokineStorm #COVID19 @CHFS_Aquadex Aquadex SmartFlow™ system to rapidly clear cytokines, including interleukin 6 (IL-6), from the blood. Removal of cytokines from the blood may improve the condition of patients suffering from #COVIDー19 ..."
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
RT @NatRevImmunol: COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM
COVID-19: immunopathology and its implications for therapy https://t.co/kqW86wZDCM